There are many types of cancers in children that are very different from those found in adults: leukaemia, lymphoma, and brain tumours are rather common in children. Acute lymphoblastic leukaemia (ALL) is the most common type of malignancy encountered. The role of pediatric dentist is very important before, during and after therapy: up to 24% of life-threatening infections arise from oral sites and areas. Early dental intervention and preventions procedures may significantly reduce oral complications associated with myelosuppressive cancer treatment. It is really important to evaluate the oral health surveys and to cut out potential sources of infection in mouth in these patients concurrent with their medical therapy. The aim of this review is summarizing the main features of oral mucositis in Childhood Acute Lymphoblastic Leukaemia, providing a little review for the approach, diagnosis and treatment of oral mucositis of ALL, which is frequent and potentially dangerous: it's important considering oral lesions of this type of childhood cancer in order to prevent complications before, during and after chemo or radio therapy to improve the quality of life of little patients.
There are many types of cancers in children that are very different from those found in adults: leukaemia, lymphoma, and brain tumours are rather common in children. Acute lymphoblastic leukaemia (ALL) is the most common type of malignancy encountered. World Health Organisation Cancer Mortality Database estimate 35.3 % ofdeaths from neoplasia in childhood is leukaemic forms. About 250000 new cases of leukaemia and 195000 deaths are registered every year all over the world(l).
From Oncolgy Nursing Forum of May 2011 we know that survival rates for childhood ALL have improved significantly over the past 50 years, such that the current five-year survival rate exceeds 85%. (2) .
Acute lymphoblastic leukemia (ALL) is a clonal neoplastic disorder originating from lymphoid progenitors in the bone marrow, thymus and lymph nodes. About 80% of ALL are malignant proliferations of precursors of the B chain, while 20% include the frameworks of the involvement of the supply chain precursors T. It is a condition affecting both pediatric and adult population with peak prevalence between 2 and 5 years: ALL represents 80% ofleukemias in children and young people under 15 years, and represents 20% of leukemia in the adult forms (3).
The etiology of ALL is unknown. Like other cancers this disease develops as a result of interactions of genetic and environmental conditions, such as important mutations in progenitor cells which are going to differentiate into T or B cells. It was also noted a certain familiarity especially in brothers, sisters and in twins: there is a 2-4 times higher risk of contracting the disease than in the average population and the risk is even greater in twins. However, there are some medical conditions closely associated to the develope of this disease: Fanconi and Bloom's syndrome, ataxia and teleangectasia. The risk is also increased in subjects exposed to chemicals such as benzene, cigarette smoke, pesticides, Vitamin K, or who has been previously undergone to cytotoxic treatments.
It has been shown that exposure to X-rays during pregnancy, such as excessive consumption of nitrates, may increase the incidence risk of acute lymphoblastic leukemia (3) .
Aggressive chemotherapy and irradiation could generally influence and aggravate general health and quality of life of survivors. The effects of chemotherapy or the infections correlated to it continue to be the leading causes of morbidity and mortality in patients with ALL or lymphoma today. We can see in literature that 24% of life-threatening infec tions arise from ora l sites and area s. Ear ly denta l intervention and preventions procedu res may significantly reduce ora l complications associated with myelosuppressive ca ncer treatment. It is rea lly important to evaluate the oral health surveys and to cut out pot ent ial sources of infection in mouth in these patient s concurre nt w ith their medic al therapy (4) .
T he aim of this review is summarizing the main features abo ut the approac h, diagnosis and treatm ent of ora l muc osit is, whic h are freq uent and potentiall y dangerous: it' s impo rtant co nsidering oral lesions of this type of childhood cancer in order to prevent complications before, dur ing and after chemo or radio therapy to impro ve the quality of life of little patients.
Oral mucositis
Children under chemotherapy A LL, especially thos e treated with CRT, are more likely to have oral problems related to mucositis (5) .
There arc severa l factors which influence the site and severi ty of mucositi s, such as the type of leuk em ia, the dosage of radia tion and chemot herapy treatm ent s, the health of patient and the co nditio ns of ora l hygiene before and du ring the treatm ent.
Th e most commo n ora l probl em s caused by chemotherapy or eve ntua lly radioth erap y are the inflamm ation of the mucous mem brane of the mouth (6) (Fig. I) . Today the treatm ent of so lid mal ignant tum ors and leu kem ias with cyto toxic chemotherapy has always more efficacy but it is also associated with short-and long-term side effec ts. Among the cl inicall y important acu te side effects is disru ption in the function and integ rity of the mouth . These disease-and treatmentindu ced complications may also produc e oral discomfort and pain, poor nutrition, delays in drug adm inistration, increased hospital stays and cos ts, and, in some patients, life-threatening infection (septicemi a) (7) . Intensive chcmo-radiotherapy damages the mucosal barrier of the mou th and thro at and it is often associated with severe ora l inflammation and infection, includ ing herpe s simplex, candidiasis, mucositis, and gingivi tis (8, 11) .
Normally mucositis is a state charac terize d by redn ess, loss of the epithelial barri er and ulceration : it is a disease that lasts for about 3 wee ks: starts 3-5 days after the first dose of chemotherapy, and reac hes its peak in 7-14 days. It tend s to declin e, if not over infected, especially by Candida albicans, and Herp es Simplex I. From a clini cal po int of view, mucositis is initially co nfigured as a burn ing sen sation, followed by inflamm atory changes in the so ft oral mucosa, which appea rs as erythematous eros ive and ulcerat ive lesions (F ig.2) .
So ft palate, orop harynx, buccal and labi al mucosa, floor of the mouth and the undersi de (ve ntral) and lateral surfaces of the tongue ca n be intere sted. Very often mucositi s is anticipated by a state of altered taste, especially in patients undergo ing radio therapy with cumulative dose over 30 Gy (8) . The perception of the bitter and ac id are the first to be changed. The loss of taste is close ly correlated with a decrease in the flow of saliva : a loss of sali va 's flow reduces the protection of mucou s membranes, invol ving changes on pH in the mouth with alterations on ion ic composition of saliva: this co nsequently helps the onset of dysgeusia and stimulates the onset of mucositis.
Co mplete resolution of mucositis occurs seven to fou rteen days after its onset. The neutrophils are the bod y's first line of defense. Therefore, the incid en ce and severity of infection are inversely related to their numb er.
A lthough a number of strategies and produ cts are avai lable for the man agem ent of oral mucositis, there is, as yet, no con sensus on the management of thi s conditio n other than the effec tive means of administering pain medi cation. Thi s may, in part , explain the reason for the current standard treatm ent for ora l muc osit is bein g symptomatic care with analges ics and nutritional support. Latest biolo gical models validate once again the association betwe en correct procedures of oral hygiene and improve ment of mucosit is, where the endotox ins due to bacteria colonizers, can amplify the cytokine cascade and thus exacerbate the damages to the mucosa (12) . So there's usually an equality in the dental and nursing literature about the institution of good and consistent oral hygiene (9) .
Today, according to the common clinical experience, it is common to practically prevent oral mucositis prescribing mouthwash with sodium bicarbonate, chlorhexidine and saline solutions and diphenhydramine and lidocaine 2% 10 ml for the relief of pain spit out after 30 seconds like a local anesthetic. It can be used paste containing Sucralfate to promote tissue regeneration (9, 13) .
Chlorhexidine seems to be the best therapy prescription for prevention, reducing the severity and duration of mucositis the key is the correct dosage because this drug has destroying potentiality against the oral mucosa (10, 14) . There are few studies in which the role of chlorexidine is still discussing because of its irritant effect on oral mucosa.
There's generally a reduction in the incidence of mucositis up to 60% during the period of neutropenia related to implementation of the protocols of oral hygiene: but it depends on, as already mentioned, many variables (chemotherapy dosage, drug clearance, immunological local and systemic levels).
CONCLUSION
Dentists playa very important role in leukemic patient especially in prevention of oral mucositis. Our review we would analyze a protocol which could help us to prevent the onset of oral mucositis during antiblastic therapy to improve the quality of life ofleukemic children.
